Migraine Clinic

All information about migraine research, migraine diagnostics, migraine therapy, headache research, headache diagnostics and headache therapy

June 18, 2024 June 18, 2024

Treating migraine attacks during pregnancy

How to treat migraine attacks during pregnancy? Mild migraine attacks during pregnancy should be treated non-medication by means of isolation, rest, relaxation and ice packs. For nausea and vomiting, metoclopramide can be used throughout pregnancy [...]

January 30, 2023 January 30, 2023

10 questions to prevent chronic migraines

1) What are the risk factors for chronic migraines? The central risk factors are reduced quality of life and high levels of suffering caused by migraines. A poor effect of acute medication, overuse of painkillers and triptans as well as comorbidities such as depression, [...]

December 3, 2022 December 3, 2022

How is migraine treated in children?

How do you distinguish the symptoms of migraines in children from those in adults? Approximately 5% of children suffer from migraines up to the age of 10. Migraine attacks in children are often not recognized in a timely manner. They differentiate [...]

November 14, 2022 November 14, 2022

1st place nationwide for the Kiel Pain Clinic for outstanding patient dialogue

Düsseldorf/Kiel November 14, 2022. The Kiel Pain Clinic received today the Federal Health Minister Prof. Dr. Karl Lauterbach took first place nationwide in the Patient Dialogue Award in the area of ​​priority care at the opening event of the German Hospital Day in Düsseldorf. The price marks [...]

October 27, 2022 October 27, 2022

New DGS practice guidelines: acute therapy and prevention of migraines

The German Society for Pain Medicine (DGS) published the practice guideline “Primary Headache Disorders” for the first time in 2014. The aim of the practice guidelines is to provide practical, practical instructions and assistance for the diagnosis and treatment of primary headaches in the area of ​​[...]

August 16, 2022 August 16, 2022

Migraine Special Care Contract for CGRP Monoclonal Antibodies

Guiding principles of specialized migraine care with CGRP monoclonal antibodies Migraine is a very common, severely disabling primary headache disorder. With its over 48 subtypes, it is one of the particularly complex neurological diseases. Epidemiological studies prove their high prevalence [...]

July 31, 2022 July 31, 2022

SDRIFE or Baboon Syndrome

Symmetrical drug-related intertriginous and flexural rash (SDRIFE or Baboon syndrome) in migraine therapy The symmetrical drug-related intertriginous and flexural rash (SDRIFE), previously also called baboon syndrome, is caused by a [...]

March 8, 2022 March 8, 2022

Migraines in women's lives

Migraines occur two to three times more in women than in men. Migraines are the most common cause of disability in women ages 15 to 49. It has a much more significant impact on the [...]

August 10, 2021 August 10, 2021

CLUSTER HEADACHES 2021 – September 11th, 2021 in Kiel

The anniversary congress on the 20th anniversary of the founding of the Federal Association of Cluster Headache Self-Help Groups (CSG) eV Suicide headache, orphan of medicine, headache nameless: The names testify to the time when the medical care system hardly knew cluster headache, did not diagnose it and [ ...]

May 13, 2021 May 13, 2021

Corticoids and vaccination against SARS-CoV-2

How do corticoids affect vaccination against SARS-CoV-2 for migraines, cluster headaches and other headaches? Therapy with prednisolone and other corticoids ("cortisone"), for example for the treatment of status migraenosus, cluster headaches or for the treatment of rebound headaches during a [...]

March 15, 2021 March 15, 2021

Renewed suspensions of vaccination with the COVID-19 vaccine AstraZeneca

Due to a recommendation from the Paul Ehrlich Institute (PEI) on March 15, 2021, the federal government suspended corona vaccinations with AstraZeneca as a precautionary measure. Further investigations were necessary. The European Medicines Agency (EMA) examined whether and how the new findings affect the [...]

July 16, 2020 July 16, 2020

FOCUS Top Medicine 2020 Pain therapy, migraines, headaches, back pain

Prof. Dr. Hartmut Göbel Prof. Dr. med. Hartmut Göbel, head physician at the Kiel Pain Clinic, is one of Germany's top doctors in the field of pain therapy according to the editorial team of Focus Health based on an independent assessment. The [...]

April 7, 2019 April 7, 2019

Special print on the migraine app study 2019

Kiel, April 7, 2019. The first scientific analysis of the therapeutic behavior of migraine and headache patients when receiving digital therapy support with the migraine app was published today in the current print edition of the scientific journal Der Pain. It is about [...]

October 26, 2018 October 26, 2018

Prevent migraine attacks with immunotherapy

The diseases headache and migraine not only affect the lives of those affected, but also cause economic damage. Newly developed antibodies intervene specifically in the molecular development process of migraines and can therefore preventively reduce the likelihood [...]

September 3, 2018 September 3, 2018

Migraine Awareness Week 2018 – Migraine Awareness Week 2018

The first week of September is used internationally to educate people about migraines in order to raise awareness of the great importance of the health problem. Prejudices and stigmas should be reduced. Prof. Hartmut Göbel answers current questions about migraines, their effects [...]